Cargando…

Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists

The purpose of this narrative review is to bring together the most recent epidemiologic, preclinical, and clinical findings to offer our perspective on best practices for managing patients with A. baumannii infections with an emphasis on carbapenem-resistant A. baumannii (CRAB). To date, the preferr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdul-Mutakabbir, Jacinda C., Griffith, Nicole C., Shields, Ryan K., Tverdek, Frank P., Escobar, Zahra Kassamali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514811/ https://www.ncbi.nlm.nih.gov/pubmed/34648177 http://dx.doi.org/10.1007/s40121-021-00541-4

Ejemplares similares

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

1542. The Evaluation of the In Vitro Synergy of Colistin in Combination with Meropenem and Tigecycline against 50 Multi-Drug-resistant Acinetobacter baumannii strains
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

1297. In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C, et al.
Publicado: (2020)

Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii
por: Moussa, Samir H., et al.
Publicado: (2023)

620. Identifying the Role for a Pharmacist on an Outpatient Parenteral Antimicrobial Therapy (OPAT) Team in an Academic Teaching Hospital
por: Hino, Garret H, et al.
Publicado: (2021)

A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii
por: Hujer, Andrea M., et al.
Publicado: (2021)

Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
por: FakhriRavari, Alireza, et al.
Publicado: (2022)

Leveraging Black pharmacists to promote equity in COVID‐19 vaccine uptake within Black communities: A framework for researchers and clinicians
por: Abdul‐Mutakabbir, Jacinda C., et al.
Publicado: (2022)

Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2022)

Insights into Acinetobacter baumannii protective immunity
por: Jeffreys, Sean, et al.
Publicado: (2022)

1858. Examining the Racial Differences in Polymicrobial Bacteremia Infections in an Area of Varying Social Vulnerability
por: Tan, Karen K, et al.
Publicado: (2023)

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections
por: Shields, Ryan K, et al.
Publicado: (2023)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

The Mechanisms of Disease Caused by Acinetobacter baumannii
por: Morris, Faye C., et al.
Publicado: (2019)

Speaker demographics at the Society for Healthcare Epidemiology of America (SHEA) Spring Conference, 2019–2022
por: Cichon, Catherine J., et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Pan-Resistome Insights into the Multidrug Resistance of Acinetobacter baumannii
por: Rodrigues, Diego Lucas Neres, et al.
Publicado: (2021)

adeABC efflux gene in Acinetobacter baumannii
por: Xu, C., et al.
Publicado: (2019)

Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
por: Antunes, Luísa C. S., et al.
Publicado: (2011)

Towards the complete small RNome of Acinetobacter baumannii
por: Weiss, Andy, et al.
Publicado: (2016)

Generation of Synthetic Acinetobacter baumannii-Specific Nanobodies
por: Knauf, Gregory A., et al.
Publicado: (2023)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Acinetobacter baumannii in Human Body Louse
por: La Scola, Bernard, et al.
Publicado: (2004)

Acinetobacter baumannii: An emerging opportunistic pathogen
por: Howard, Aoife, et al.
Publicado: (2012)

Reservoirs of Non-baumannii Acinetobacter Species
por: Al Atrouni, Ahmad, et al.
Publicado: (2016)

Iron and Acinetobacter baumannii Biofilm Formation
por: Gentile, Valentina, et al.
Publicado: (2014)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Structure and Evolution of Acinetobacter baumannii Plasmids
por: Salgado-Camargo, Abraham D., et al.
Publicado: (2020)

Acinetobacter baumannii Antibiotic Resistance Mechanisms
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

Molecular characterisation of an Acinetobacter baumannii outbreak
por: Al-Hassan, Leena L., et al.
Publicado: (2020)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

Genomics of Acinetobacter baumannii iron uptake
por: Artuso, Irene, et al.
Publicado: (2023)

Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis
por: Colquhoun, Jennifer M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjb8bicg45s29pfhll84i7k7s0